XML 29 R17.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock Compensation Plans
 3 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Stock Compensation Plans STOCK COMPENSATION PLANS
The Company has two active stock compensation plans: the 2014 Equity Incentive Plan and the 2019 Equity Incentive Plan. Under the Company's 2014 Equity Incentive Plan, the Company may grant options and awards of restricted stock (with or without performance measures) for up to 352,366 shares of common stock to employees, officers, directors and directors emeriti. Under the Company's 2019 Equity Incentive Plan, the Company may grant options and awards of restricted stock (with or without performance measures) for up to 350,000 shares of common stock, of which 300,000 shares are reserved to be awarded to employees and officers, and 50,000 shares are reserved to be awarded to directors and directors emeriti.  Shares issued may be purchased in the open market or may be issued from authorized and unissued shares.  The exercise price of each option equals the fair market value of the Company’s common stock on the date of grant. Generally, options and restricted stock vest in equal annual installments commencing on the first anniversary of the grant date. Stock options generally vest over a five year period from the date of the grant with a maximum contractual term of ten years from the date of grant. Restricted stock grants generally vest over a three or five year term from the grant date. At December 31, 2024, there were 15,576 and 155,705 shares of common stock available which may be awarded as options or restricted stock pursuant to future grants under the 2014 and 2019 Equity Incentive Plans, respectively.

Stock option activity for the three months ended December 31, 2024 and 2023 is summarized as follows:
 Three Months Ended December 31, 2024Three Months Ended December 31, 2023
  Number of SharesWeighted
Average
Exercise
Price		 Number of SharesWeighted
Average
Exercise
Price
Options outstanding, beginning of period306,240 $25.21 369,150 $24.00 
Exercised(22,400)21.17 (27,700)12.81 
Forfeited(600)27.40 (5,380)25.10 
Options outstanding, end of period283,240 $25.52 336,070 $24.91 

The fair value of stock options is determined using the Black-Scholes valuation model.

There were no stock options granted during the three months ended December 31, 2024 and 2023.

The aggregate intrinsic value of options exercised during the three months ended December 31, 2024 and 2023 was $239,000 and $469,000, respectively.

At December 31, 2024, there were 76,530 unvested options with an aggregate grant date fair value of $464,000, all of which the Company assumes will vest. The aggregate intrinsic value of unvested options at December 31, 2024 was $328,000.  There were 100 options that vested during the three months ended December 31, 2024 with a total fair value of $326.
At December 31, 2023, there were 124,640 unvested options with an aggregate grant date fair value of $725,000. There were 100 options that vested during the three months ended December 31, 2023 with a total fair value of $326.
Additional information regarding options outstanding at December 31, 2024 is as follows:

 Options OutstandingOptions Exercisable
Range of
Exercise
Prices ($)		NumberWeighted
Average
Exercise
Price 		Weighted
Average
Remaining
Contractual
Life (Years)		NumberWeighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Life (Years)
10.26-10.7114,750 $10.62 0.514,750 $10.62 0.5
15.67-19.1350,750 16.57 4.739,920 16.48 4.5
26.50-27.4091,020 27.32 6.951,720 27.25 6.1
28.23-29.6995,400 28.80 5.269,800 29.01 4.6
31.80-33.4031,320 31.85 3.930,520 31.59 3.8
 283,240 $25.52 5.3206,710 $25.25 4.5

The aggregate intrinsic value of options outstanding at December 31, 2024 and 2023 was $1.45 million and $2.22 million, respectively.

As of December 31, 2024, unrecognized compensation cost related to unvested stock options was $437,000, which is expected to be recognized over a weighted average period of 1.60 years.

There were no restricted stock awards granted during the three months ended December 31, 2024 and 2023.

Three Months Ended December 31, 2024Three Months Ended December 31, 2023
Number of Unvested SharesWeighted Average Grant Date Fair ValueNumber of Unvested SharesWeighted Average Grant Date Fair Value
Restricted stock outstanding beginning of period49,015 $29.28 26,150 $27.37 
     Forfeited(450)29.28 — — 
Restricted stock outstanding end of period48,565 $29.28 26,150 $27.37 
The fair value of restricted stock awards is equal to the fair value of the Company's stock on the date of the grant. The related stock-based compensation expense is recorded over the requisite service period. At December 31, 2024, unrecognized compensation cost related to unvested restricted stock awards was $1.34 million, which is expected to be recognized over a weighted average period of 2.45 years.